Literature DB >> 8822954

Molecular analysis of glucose phosphate isomerase deficiency associated with hereditary hemolytic anemia.

H Kanno1, H Fujii, A Hirono, Y Ishida, S Ohga, Y Fukumoto, K Matsuzawa, S Ogawa, S Miwa.   

Abstract

We report here two new cases of glucose phosphate isomerase (GPI) deficiency associated with hemolytic anemia and present the results of molecular analysis of the five Japanese GPI variants. A Japanese girl (GPI Fukuoka) had an episode of prolonged neonatal jaundice and at 3 years of age was admitted due to acute hemolytic crisis occurring with upper respiratory tract infection. Red blood cell (RBC) GPI activity was decreased to 11.8% of normal and the reduced glutathione (GSH) level of RBCs was slightly decreased. A 54-year-old Japanese man (GPI Iwate) was hospitalized due to chronic active hepatitis, and compensated hemolysis was noted. RBC GPI activity of the proband was decreased to 18.8%, and the GSH content was about half of the normal mean value. Sequencing of the reticulocyte GPIcDNA showed homozygous missense mutations 1028CAG-->CGG (343Gln-->Arg), 14ACC-->A7C (5Thr-->lle), 671ACG-->A7G (224Thr-->Met), and 1615GAC-->AAC (539Asp-->Asn) in GPI Narita, GPI Matsumoto, GPI Iwate, and GPI Fukuoka, respectively. We also identified GPI Kinki as a compound heterozygote of 1124ACA-->AGA(375Thr-->Arg)/ 1615GAC-->AAC(539Asp-->Asn). Our findings, together with the previous results of other investigators, showed that the GPI gene mutations so far identified were heterogeneous, although most GPI variants had common biochemical characteristics such as heat instability and normal kinetics. Several amino acid substitutions were identified in the proximity of the catalytically important amino acid residues such as Ser/Asp 159/160, Asp341, and Lys518, which have been identified in the structural analysis of the pig GPI. The molecular characterization of human GPI variants, therefore, may provide new insights into the genotype-phenotype correlation of GPI deficiency as well as the structure-function relationship of this enzyme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8822954

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  The molecular basis of disorders of red cell enzymes.

Authors:  M F McMullin
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

2.  Glucose-6-phosphate isomerase deficiency results in mTOR activation, failed translocation of lipin 1α to the nucleus and hypersensitivity to glucose: Implications for the inherited glycolytic disease.

Authors:  Jorge F Haller; Sarah A Krawczyk; Lubov Gostilovitch; Barbara E Corkey; Raphael A Zoeller
Journal:  Biochim Biophys Acta       Date:  2011-07-21

3.  Glucose Phosphate Isomerase Deficiency: High Prevalence of p.Arg347His Mutation in Indian Population Associated with Severe Hereditary Non-Spherocytic Hemolytic Anemia Coupled with Neurological Dysfunction.

Authors:  Prabhakar S Kedar; Rashmi Dongerdiye; Pooja Chilwirwar; Vinod Gupta; Ashish Chiddarwar; Rati Devendra; Prashant Warang; Harsha Prasada; Abhilasha Sampagar; Sunil Bhat; S Chandrakala; Manisha Madkaikar
Journal:  Indian J Pediatr       Date:  2019-04-27       Impact factor: 1.967

4.  Diagnosis and clinical management of enzymopathies.

Authors:  Lucio Luzzatto
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 5.  Nutrigenomic basis of beneficial effects of chromium(III) on obesity and diabetes.

Authors:  Francis C Lau; Manashi Bagchi; Chandan K Sen; Debasis Bagchi
Journal:  Mol Cell Biochem       Date:  2008-07-18       Impact factor: 3.396

6.  Glucose 6-Phosphate Accumulates via Phosphoglucose Isomerase Inhibition in Heart Muscle.

Authors:  Anja Karlstaedt; Radhika Khanna; Manoj Thangam; Heinrich Taegtmeyer
Journal:  Circ Res       Date:  2019-11-08       Impact factor: 17.367

7.  Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic Redundancy.

Authors:  Lin Wu; Kate E R Hollinshead; Yuhan Hao; Christy Au; Lina Kroehling; Charles Ng; Woan-Yu Lin; Dayi Li; Hernandez Moura Silva; Jong Shin; Juan J Lafaille; Richard Possemato; Michael E Pacold; Thales Papagiannakopoulos; Alec C Kimmelman; Rahul Satija; Dan R Littman
Journal:  Cell       Date:  2020-07-01       Impact factor: 41.582

8.  Functional phosphoproteomic analysis reveals cold-shock domain protein A to be a Bcr-Abl effector-regulating proliferation and transformation in chronic myeloid leukemia.

Authors:  D Sears; P Luong; M Yuan; G Nteliopoulos; Y K S Man; J V Melo; S Basu
Journal:  Cell Death Dis       Date:  2010-11-04       Impact factor: 8.469

9.  Successful treatment of fetal hemolytic disease due to glucose phosphate isomerase deficiency (GPI) using repeated intrauterine transfusions: a case report.

Authors:  Phebe N Adama van Scheltema; Ai Zhang; Lynne M Ball; Sylke J Steggerda; Richard van Wijk; Dietje E Fransen van de Putte; Inge L van Kamp
Journal:  Clin Case Rep       Date:  2015-09-07

10.  Oxidation Resistance 1 Modulates Glycolytic Pathways in the Cerebellum via an Interaction with Glucose-6-Phosphate Isomerase.

Authors:  Mattéa J Finelli; Teresa Paramo; Elisabete Pires; Brent J Ryan; Richard Wade-Martins; Philip C Biggin; James McCullagh; Peter L Oliver
Journal:  Mol Neurobiol       Date:  2018-06-15       Impact factor: 5.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.